Rees R C, Parker S, Platts A, Blackburn M G, MacNeil S
Department of Virology, University of Sheffield Medical School.
Biosci Rep. 1987 Oct;7(10):771-5. doi: 10.1007/BF01116749.
The calmodulin antagonist W7 and 4 of its analogues were examined for their ability to inhibit human NK cell mediated cytotoxicity. With the exception of one of these compounds, which is extremely hydrophobic, there was a good correlation between the ability of drugs to inhibit human NK antitumour cytotoxicity and calmodulin-dependent phosphodiesterase activity in vitro. The most potent of the compounds, 5-iodo-1-C8, an analogue of W7, has an IC50 of 3 microM upon biological and biochemical assay. This particular compound is both more potent and specific than the parent compound W7, is non-toxic to cells over the range used and is also capable of inhibiting the biological activity of NK cells upon pre-treatment of the effector cells, inferring the mechanism of NK cytotoxicity to be calmodulin dependent.
研究了钙调蛋白拮抗剂W7及其4种类似物抑制人自然杀伤(NK)细胞介导的细胞毒性的能力。除了其中一种极其疏水的化合物外,这些药物在体外抑制人NK抗肿瘤细胞毒性的能力与钙调蛋白依赖性磷酸二酯酶活性之间存在良好的相关性。这些化合物中最有效的是W7的类似物5-碘-1-C8,经生物学和生化测定,其半数抑制浓度(IC50)为3微摩尔。这种特定的化合物比母体化合物W7更有效且更具特异性,在所使用的浓度范围内对细胞无毒,并且在对效应细胞进行预处理后也能够抑制NK细胞的生物学活性,这表明NK细胞毒性的机制是钙调蛋白依赖性的。